ClinicalTrials.gg
Sign In

Leukemia, Mast-Cell clinical trials

The registry lists 60 studies for Leukemia, Mast-Cell across more than 10 countries. 5 are recruiting or about to start. 13 of them are mainly about Leukemia, Mast-Cell (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-28.

Get an email when these change. Save the Leukemia, Mast-Cell studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
37
Terminated
7
Withdrawn
5
Active, not recruiting
3
Recruiting
3
Status unknown
2

Phase

Phase 2
21
Phase 1
10
Phase 3
5
Early Phase 1
1

Where

United States
48
United Kingdom
7
Germany
7
Italy
6
Canada
6
Spain
5

Who runs them

Fred Hutchinson Cancer Center (6) · Blueprint Medicines Corporation (5) · Wake Forest University Health Sciences (4) · M.D. Anderson Cancer Center (4) · Jason Robert Gotlib (3) · UNC Lineberger Comprehensive Cancer Center (3) · National Cancer Institute (NCI) (3) · Novartis Pharmaceuticals (3)

What is being tested here

Drugs under test in Leukemia, Mast-Cell studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Fludarabine106
Allogeneic CD34+-enriched and CD45RA-depleted PBSCs101
Cyclophosphamide101
Bezuclastinib101
Fludarabine phosphate005
Cyclosporine003
Mycophenolic Acid003
Avapritinib002
Midostaurin002
Sunitinib002

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 1 open · Antimetabolites 1 open

Coming up

0phase 3 studies under way
1study finishes main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The study

Who these studies take

Of the 3 Leukemia, Mast-Cell studies recruiting now, 2 (67%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 3
AgeWomenMen
100 (0%)0 (0%)
182 (67%)2 (67%)
302 (67%)2 (67%)
402 (67%)2 (67%)
502 (67%)2 (67%)
653 (100%)3 (100%)
753 (100%)3 (100%)
853 (100%)3 (100%)

Across all 60 studies, recruiting or not: 23% stop at 75 or younger and 13% at 65; 33% take children; 0% are for women only and 0% for men only; 5% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 60. Browse all 60 → or search them.